PharmaIN's Reversible Binding (PRB™) is a key component to our novel approach to drug delivery. PharmaIN scientists employ the use of reversible binding chemistries to attach drug payloads to our proprietary carrier molecules. The use of reversible binding (i.e. non-covalent binding) provides several advantages over existing drug delivery technologies:

1) preserves the structure and activity of the active drug payload

2) typically does NOT require modification of the active drug molecule to be delivered

3) is designed to favor release of drug payload at the receptor site, or action site for a drug

4) can potentially avoid "new chemical entity" status for regulatory purposes, thus accelerating product development and commercialization opportunities

5) not limited to one form of binding technology or chemistry

6) formulations can be created quickly, readied for preclinical testing in a matter of a months in many instances